231 related articles for article (PubMed ID: 25943258)
21. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.
Martín-Blázquez A; Díaz C; González-Flores E; Franco-Rivas D; Jiménez-Luna C; Melguizo C; Prados J; Genilloud O; Vicente F; Caba O; Pérez Del Palacio J
Sci Rep; 2019 Dec; 9(1):20198. PubMed ID: 31882610
[TBL] [Abstract][Full Text] [Related]
22. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
23. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
Cancer Metab; 2016; 4():11. PubMed ID: 27275383
[TBL] [Abstract][Full Text] [Related]
24. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
Chen L; Zhang C; Gui Q; Chen Y; Yang Y
Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
[TBL] [Abstract][Full Text] [Related]
25. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
[TBL] [Abstract][Full Text] [Related]
26. Urinary charged metabolite profiling of colorectal cancer using capillary electrophoresis-mass spectrometry.
Udo R; Katsumata K; Kuwabara H; Enomoto M; Ishizaki T; Sunamura M; Nagakawa Y; Soya R; Sugimoto M; Tsuchida A
Sci Rep; 2020 Dec; 10(1):21057. PubMed ID: 33273632
[TBL] [Abstract][Full Text] [Related]
27. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
28. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract][Full Text] [Related]
29. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
Li Y; Wang C; Li D; Deng P; Shao X; Hu J; Liu C; Jie H; Lin Y; Li Z; Qian X; Zhang H; Zhao Y
Oncol Rep; 2017 Nov; 38(5):3044-3054. PubMed ID: 28901465
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study.
Zaimenko I; Jaeger C; Brenner H; Chang-Claude J; Hoffmeister M; Grötzinger C; Detjen K; Burock S; Schmitt CA; Stein U; Lisec J
Int J Cancer; 2019 Jul; 145(1):221-231. PubMed ID: 30560999
[TBL] [Abstract][Full Text] [Related]
31. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
32. Selective paired ion contrast analysis: a novel algorithm for analyzing postprocessed LC-MS metabolomics data possessing high experimental noise.
Mak TD; Laiakis EC; Goudarzi M; Fornace AJ
Anal Chem; 2015 Mar; 87(6):3177-86. PubMed ID: 25683158
[TBL] [Abstract][Full Text] [Related]
33. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics analyses of cancer tissue from patients with colorectal cancer.
Kang C; Zhang J; Xue M; Li X; Ding D; Wang Y; Jiang S; Chu FF; Gao Q; Zhang M
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772396
[TBL] [Abstract][Full Text] [Related]
35. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry.
Mal M; Koh PK; Cheah PY; Chan EC
Anal Bioanal Chem; 2012 Apr; 403(2):483-93. PubMed ID: 22374317
[TBL] [Abstract][Full Text] [Related]
36. Metabolic profiling analysis for clinical urine of colorectal cancer.
Ning W; Qiao N; Zhang X; Pei D; Wang W
Asia Pac J Clin Oncol; 2021 Aug; 17(4):403-413. PubMed ID: 34164923
[TBL] [Abstract][Full Text] [Related]
37. LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.
Peng W; Tan S; Xu Y; Wang L; Qiu D; Cheng C; Lin Y; Liu C; Li Z; Li Y; Zhao Y; Li Q
Oncol Rep; 2018 Aug; 40(2):1026-1034. PubMed ID: 29989648
[TBL] [Abstract][Full Text] [Related]
38. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
39. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
40. Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry.
Wang W; Feng B; Li X; Yin P; Gao P; Zhao X; Lu X; Zheng M; Xu G
Mol Biosyst; 2010 Oct; 6(10):1947-55. PubMed ID: 20617254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
